Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» liver cancer
liver cancer
Bayer says Nexavar-Tarceva trial unsuccessful
Reuters
Mon, 07/23/12 - 08:55 am
Nexavar
Tarceva
Bayer
liver cancer
ONYX Pharmaceuticals
Cramer: What Celgene’s Europe News Means
CNBC
Sat, 06/23/12 - 12:00 pm
Celgene
Revlimid
ONYX Pharmaceuticals
kidney cancer
liver cancer
New Drug Could Be Game Changer For Sanofi
Seeking Alpha
Thu, 05/31/12 - 06:11 pm
Sanofi
liver cancer
GSK
AstraZeneca
Bristol-Myers Squibb
India licenses generic copy of patented Bayer drug
Yahoo/AP
Mon, 03/12/12 - 05:45 pm
Bayer
generics
India
liver cancer
kidney cancer
sorefinib
Natco
Bristol-Myers Says Liver Cancer Drug Didn’t Meet Goals in Trial
Bloomberg
Fri, 12/23/11 - 08:44 am
liver cancer
Bristol-Myers Squibb
brivanib
Nexavar
ONYX Pharmaceuticals
Bayer
Celsion Completes Consultative Review Process With EMA for Phase III HEAT Study of ThermoDox(R) in Primary Liver Cancer
Mon, 12/19/11 - 06:05 pm
Celsion
EMA
ThermoDox
hepatocellular carcinoma
liver cancer
radio frequency ablation
3 Cancer-Fighting Stocks That Could Deliver Huge Gains
Seeking Alpha
Sat, 10/8/11 - 11:46 am
ThermoDox
Celsion
liver cancer
Threshold Pharmaceuticals
TH-302
leukemia
Medivation
dimebon
Alzheimer's disease
MDV3100
prostate cancer
Pfizer
Celsion Announces Publication of Clinical and Scientific Review of ThermoDox(R) as Treatment for Primary Liver Cancer
Wed, 08/17/11 - 10:38 pm
Celsion
Publication
clinical trials
research
cancer
liver cancer
Alnylam Presents Phase I Data for ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancers, at American Society of Clinical Oncology (ASCO) Meeting
Yahoo/BusinessWire
Sun, 06/5/11 - 10:04 am
Alnylam
liver cancer
ALN-VSP
RNAi
Cancer Treatment Experts Detail Promising New Radiosurgical Techniques for Lung and Liver Cancer Patients
Thu, 05/12/11 - 07:13 pm
cancer
radiosurgery
lung cancer
liver cancer
Celsion Receives European Orphan Drug Designation for ThermoDox(R) to Treat Primary Liver Cancer
Wed, 03/2/11 - 05:09 pm
Celsion
Europe
ThermoDox
liver cancer
Undervalued Apricus Bio Poised to Follow Threshold Pharma in Receiving SPA Approval
Seeking Alpha
Thu, 02/17/11 - 01:02 pm
Apricus Biosciences
liver cancer
ProvOnco
Threshold Pharmaceuticals
Boston Scientific's Renegade device gets FDA nod
Mon, 01/31/11 - 04:26 pm
Boston Scientific
Renegade
FDA
approvals
uterine fibroids
liver cancer
Good News for Merit Medical
Wed, 12/1/10 - 04:13 pm
Merit Medical Systems
liver cancer
QuadraSphere
Good News for Merit Medical
Wed, 12/1/10 - 04:13 pm
Merit Medical Systems
liver cancer
QuadraSphere
Apricus, FDA agree on design for late-stage study of liver cancer drug PrevOnco; stock surges
Yahoo/AP
Mon, 11/22/10 - 12:35 pm
Apricus Biosciences
FDA
liver cancer
PrevOnco
Data Monitoring Committee Unanimously Recommends Continuation of Celsion's Phase III ThermoDox® HEAT Study to Treat Primary Liver Cancer
Thu, 09/30/10 - 12:32 pm
liver cancer
Celsion
ThermoDox
Data Monitoring Comittee
oncology
Pfizer and SMC Collaborate on Liver Cancer
Yahoo
Wed, 07/14/10 - 10:39 am
Pfizer
SMC
liver cancer
Bayer’s Nexavar Fails to Win Backing of U.K. Agency
Bloomberg
Wed, 05/26/10 - 08:49 am
Bayer
UK
Nexavar
liver cancer
Pfizer ends trial of Sutent in liver cancer
Yahoo/AP
Fri, 04/23/10 - 07:58 am
Pfizer
clinical trials
liver cancer
Sutent
Nexavar
Bayer
ONYX Pharmaceuticals
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »